{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:05:50Z","timestamp":1790456750851,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.japh.2024.102154","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T14:10:44Z","timestamp":1719929444000},"page":"102154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Polypharmacy among adults with asthma in the United States, 2005-2020"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3485-9775","authenticated-orcid":false,"given":"Chun-Tse","family":"Hung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7376-5643","authenticated-orcid":false,"given":"Yu-Chien","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Won","family":"Suk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding-Cheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10258","key":"10.1016\/j.japh.2024.102154_bib1","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.japh.2024.102154_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.anai.2018.03.024","article-title":"Barriers to medication adherence in asthma: the importance of culture and context","volume":"121","author":"McQuaid","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.japh.2024.102154_bib5","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1183\/09031936.00075614","article-title":"Medication adherence and the risk of severe asthma exacerbations: a systematic review","volume":"45","author":"Engelkes","year":"2015","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.japh.2024.102154_bib6","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.anai.2023.07.013","article-title":"Cost-related medication nonadherence in US adults with asthma: the national health interview survey, 2013-2020","volume":"131","author":"Xia","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.japh.2024.102154_bib7","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/02770903.2020.1711916","article-title":"Prevalence and predictors of adherence to inhaled corticosteroids in young adults (15-30 years) with asthma: a systematic review and meta-analysis","volume":"58","author":"Murphy","year":"2021","journal-title":"J\u00a0Asthma"},{"issue":"2","key":"10.1016\/j.japh.2024.102154_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40264-015-0378-5","article-title":"Appropriate polypharmacy and medicine Safety: when Many is not Too Many","volume":"39","author":"Cadogan","year":"2016","journal-title":"Drug Saf"},{"key":"10.1016\/j.japh.2024.102154_bib9","series-title":"Medication Safety in Polypharmacy.Geneva: World health Organization","year":"2019"},{"issue":"1","key":"10.1016\/j.japh.2024.102154_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s41256-023-00311-4","article-title":"Prevalence and trends of polypharmacy in U.S. adults, 1999-2018","volume":"8","author":"Wang","year":"2023","journal-title":"Glob Health Res Policy"},{"issue":"9","key":"10.1016\/j.japh.2024.102154_bib12","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/pds.5310","article-title":"Polypharmacy and the risk of drug-drug interactions and potentially inappropriate medications in hospital psychiatry","volume":"30","author":"Wolff","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.japh.2024.102154_bib13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00228-021-03207-9","article-title":"Improving medication adherence and effective prescribing through a patient-centered prescription model in patients with multimorbidity","volume":"78","author":"Gonz\u00e1lez-Bueno","year":"2022","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.japh.2024.102154_bib14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s40801-023-00361-7","article-title":"Patients' Perceived importance of medication and adherence in polypharmacy, a Quantitative, cross-sectional study using a questionnaire Administered in three doctors' Private Practices in France","volume":"10","author":"Reach","year":"2023","journal-title":"Drugs Real World Outcomes"},{"issue":"4","key":"10.1016\/j.japh.2024.102154_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.20452\/pamw.16250","article-title":"Asthma and comorbidities: recent advances","volume":"132","author":"Cazzola","year":"2022","journal-title":"Pol Arch Intern Med"},{"issue":"11","key":"10.1016\/j.japh.2024.102154_bib16","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/archpsyc.60.11.1125","article-title":"Mental disorders and asthma in the community","volume":"60","author":"Goodwin","year":"2003","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.japh.2024.102154_bib17","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.1038\/s41598-019-43481-3","article-title":"Increased risk of asthma in patients with rheumatoid arthritis: a longitudinal follow-up study using a national sample cohort","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.japh.2024.102154_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020270","article-title":"Factors associated with polypharmacy in primary care: a cross-sectional analysis of data from the English Longitudinal Study of Ageing (ELSA)","volume":"8","author":"Slater","year":"2018","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.japh.2024.102154_bib19","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1186\/s12913-017-2793-z","article-title":"Prevalence and determinants of polypharmacy in Switzerland: data from the CoLaus study","volume":"17","author":"Castioni","year":"2017","journal-title":"BMC Health Serv Res"},{"issue":"9","key":"10.1016\/j.japh.2024.102154_bib20","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1007\/s10067-023-06646-0","article-title":"Prevalence and factors associated with polypharmacy among patients with rheumatoid arthritis: a single-centre, cross-sectional study","volume":"42","author":"Miyake","year":"2023","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.japh.2024.102154_bib21","article-title":"Polypharmacy Pattern in Iran: a comprehensive analysis of a large prescription Database","volume":"21","author":"Ebrahimoghli","year":"2022","journal-title":"Iran J Pharm Res (IJPR)"},{"issue":"190","key":"10.1016\/j.japh.2024.102154_bib22","first-page":"1","article-title":"National health and nutrition examination survey, 2017-March 2020 Prepandemic file: sample design, estimation, and analytic guidelines","volume":"1","author":"Akinbami","year":"2022","journal-title":"Vital Health Stat"},{"issue":"3","key":"10.1016\/j.japh.2024.102154_bib23","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.sapharm.2005.06.004","article-title":"Polypharmacy trends in office visits by the elderly in the United States, 1990 and 2000","volume":"1","author":"Aparasu","year":"2005","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.japh.2024.102154_bib24","series-title":"National center for chronic disease P, health promotion Office on S, health. Publications and reports of the Surgeon general. Smoking Cessation: a Report of the Surgeon general","year":"2020"},{"issue":"1","key":"10.1016\/j.japh.2024.102154_bib25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1536867X0600600106","article-title":"Goodness-of-fit test for a logistic regression model Fitted using survey sample data","volume":"6","author":"Archer","year":"2006","journal-title":"STATA J"},{"key":"10.1016\/j.japh.2024.102154_bib27","first-page":"1","article-title":"National center for health statistics data presentation standards for Proportions","volume":"175","author":"Parker","year":"2017","journal-title":"Vital Health Stat 2"},{"issue":"3","key":"10.1016\/j.japh.2024.102154_bib28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/0897190019869158","article-title":"High levels of polypharmacy in rheumatoid arthritis-A Challenge not covered by current management Recommendations: data from a large Real-life study","volume":"34","author":"Gomides","year":"2021","journal-title":"J\u00a0Pharm Pract"},{"issue":"4","key":"10.1016\/j.japh.2024.102154_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.621","article-title":"Polypharmacy, potentially serious clinically relevant drug-drug interactions, and inappropriate medicines in elderly people with type 2 diabetes and their impact on quality of life","volume":"8","author":"Al-Musawe","year":"2020","journal-title":"Pharmacol Res Perspect"},{"issue":"1","key":"10.1016\/j.japh.2024.102154_bib30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/acps.13435","article-title":"Determinants and consequences of polypharmacy in patients with a depressive disorder in later life","volume":"146","author":"Wiersema","year":"2022","journal-title":"Acta Psychiatr Scand"},{"issue":"702","key":"10.1016\/j.japh.2024.102154_bib31","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.3399\/bjgp21X714245","article-title":"Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a retrospective analysis on adverse outcomes in the TOPCAT trial","volume":"71","author":"Wu","year":"2021","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.japh.2024.102154_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/193168","article-title":"Chronic condition Clusters and polypharmacy among adults","volume":"2012","author":"Vyas","year":"2012","journal-title":"Int J Family Med"},{"issue":"4","key":"10.1016\/j.japh.2024.102154_bib33","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s41999-023-00777-y","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 3","volume":"14","author":"O'Mahony","year":"2023","journal-title":"Eur Geriatr Med"},{"issue":"4","key":"10.1016\/j.japh.2024.102154_bib34","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/j.1475-6773.2006.00682.x","article-title":"Utilizing new prescription drugs: disparities among non-Hispanic whites, non-Hispanic blacks, and Hispanic whites","volume":"42","author":"Wang","year":"2007","journal-title":"Health Serv Res"},{"key":"10.1016\/j.japh.2024.102154_bib35","doi-asserted-by":"crossref","DOI":"10.1590\/1980-549720200077","article-title":"Polypharmacy, socioeconomic indicators and number of diseases: results from ELSA-Brasil","volume":"23","author":"Silva","year":"2020","journal-title":"Rev Bras Epidemiol"},{"issue":"5","key":"10.1016\/j.japh.2024.102154_bib36","doi-asserted-by":"crossref","first-page":"250","DOI":"10.5694\/j.1326-5377.2005.tb06680.x","article-title":"Inhalation-device polypharmacy in asthma","volume":"182","author":"McDonald","year":"2005","journal-title":"Med J Aust"},{"issue":"2","key":"10.1016\/j.japh.2024.102154_bib37","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/jama.2015.7517","article-title":"Polypharmacy in the aging patient: management of hypertension in Octogenarians","volume":"314","author":"Benetos","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.japh.2024.102154_bib38","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12875-018-0795-5","article-title":"Polypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacy","volume":"19","author":"Rieckert","year":"2018","journal-title":"BMC Fam Pract"},{"issue":"1","key":"10.1016\/j.japh.2024.102154_bib39","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12875-023-02070-0","article-title":"The effect of polypharmacy on healthcare services utilization in older adults with comorbidities: a retrospective cohort study","volume":"24","author":"Doumat","year":"2023","journal-title":"BMC Prim Care"},{"issue":"4","key":"10.1016\/j.japh.2024.102154_bib40","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cger.2022.05.012","article-title":"Polypharmacy in the emergency department","volume":"38","author":"Nguyen","year":"2022","journal-title":"Clin Geriatr Med"},{"issue":"6","key":"10.1016\/j.japh.2024.102154_bib41","first-page":"273","article-title":"Drug interactions with oral inhaled medications","volume":"34","author":"Ajimura","year":"2018","journal-title":"J\u00a0Pharm Technol"},{"key":"10.1016\/j.japh.2024.102154_bib42","series-title":"Budesonide. StatPearls","author":"Kalola","year":"2024"},{"issue":"3","key":"10.1016\/j.japh.2024.102154_bib43","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2014.08.020","article-title":"Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature","volume":"135","author":"Rajan","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.japh.2024.102154_bib44","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1164\/rccm.201901-0016OC","article-title":"The Projected economic and health burden of Uncontrolled asthma in the United States","volume":"200","author":"Yaghoubi","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.japh.2024.102154_bib45","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1186\/s12877-023-04256-8","article-title":"What makes a multidisciplinary medication review and deprescribing intervention for older people work well in primary care? A realist review and synthesis","volume":"23","author":"Radcliffe","year":"2023","journal-title":"BMC Geriatr"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319124001742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319124001742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T13:28:54Z","timestamp":1732022934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319124001742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1544319124001742"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2024.102154","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polypharmacy among adults with asthma in the United States, 2005-2020","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2024.102154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102154"}}